Su-Chun Zhang and his team of University of Wisconsin researchers have successfully converted skin cells to nervous system cells directly, the university announced recently. Skipping the induced pluripotent stem cell (iPSC) stage…
The University of Wisconsin revealed recently a study that is the first to show results suggesting human stem cells have the ability to successfully implant themselves in the human brain…
A preliminary examination of Exact Sciences‘ Cologuard colorectal cancer screening test showed promising data for detection of colorectal cancer and pre-cancerous polyps, the company announced recently. “There is a significant unmet clinical…
After a new type of “bird flu” emerged in China, University of Wisconsin researcher Yoshihiro Kawaoka and his company FluGen began working to make flu vaccines more effective than ever, the university announced…
University of Wisconsin Professor of Biomedical Engineering William Murphy has developed a new stem cell screening process, the university announced on Wednesday. Murphy’s development, which was published recently in Nature Scientific Reports, will…
Primorigen Biosciences will accelerate work on its system for large scale production of stem cells thanks to more than $1.9 million in Phase II SBIR grants, the company announced recently….
Cellular Dynamics International announced this week that it received $16 million from the California Institute for Regenerative Medicine to create three induced pluripotent stem cell (iPSC) lines for each of 3,000 healthy…
InvivoSciences, Inc. and Torrey Pines Institute for Molecular Studies (TPIMS) announced today they will be working together to accelerate drug discovery in cardiac disease. “We are especially proud and pleased…
The Wisconsin Alumni Research Foundation will be hosting its second annual Discovery Challenge with the goal of helping young scientists take their research into the real world. University of Wisconsin…
GE Healthcare Life Sciences announced today that it will license Cellular Dynamics International (CDI) to develop, manufacture and sell cellular assays and models derived from induced pluripotent stem cells for use…
